Annual report pursuant to Section 13 and 15(d)

Consolidated Statement of Changes in Stockholders' Equity (Deficit)

v3.20.1
Consolidated Statement of Changes in Stockholders' Equity (Deficit) - USD ($)
Series Seed Preferred
Series A Preferred
Series H Preferred
Series H-3 Preferred
Series H-4 Preferred
Series H-5
Common Stock
Additional Paid-in Capital
Retained Earnings
Total
Beginning balance, shares at Dec. 31, 2017 275,691 611,944 0 0 0   374,285      
Beginning balance, amount at Dec. 31, 2017 $ 27 $ 61 $ 0 $ 0 $ 0   $ 37 $ 5,115,158 $ (9,604,897) $ (4,489,614)
Issuance of common stock for cash, shares             10,057      
Issuance of common stock for cash, amount             $ 1 299,999   300,000
Conversion of debt into common stock, shares             136,785      
Conversion of debt into common stock, amount             $ 14 3,682,488   3,682,502
Conversion of accrued interest into common stock, shares             4,518      
Conversion of accrued interest into common stock, amount               159,584   159,584
Interest on lock-up shares in relation to convertible debt, shares             85,571      
Interest on lock-up shares in relation to convertible debt, amount             $ 9 672,135   672,144
Exchange of shares in connection with Merger, shares             490,422      
Exchange of shares in connection with Merger, amount             $ 49 9,792,139   9,792,188
Conversion of outstanding Preferred Stock in connection with merger, shares (275,691) (611,944)         147,939      
Conversion of outstanding Preferred Stock in connection with merger, amount $ (27) $ (61)         $ 15 73    
Issuance of Series H-3 preferred stock in connection with merger, shares     8 2,189            
Issuance of Series H-4 preferred stock and warrants in private placement, net of costs, shares         26,843          
Issuance of Series H-4 preferred stock and warrants in private placement, net of costs, amount         $ 3     5,898,336   5,898,339
Issuance of common shares in connection with exercise of H-4 warrants, shares             260,116      
Issuance of common shares in connection with exercise of H-4 warrants, amount             $ 26 936,397   936,423
Issuance of Pre-Funded Series K Warrants net of costs of $15,000, amount               968,329   968,329
Stock based compensation for options issued to employees               434,555   434,555
Stock based compensation for restricted stock units issued to employees               2,954,124   2,954,124
Stock based compensation for common stock issued to service providers, shares             60,262      
Stock based compensation for common stock issued to service providers, amount             $ 6 478,979   478,985
Common stock reserved and retired for excess tax benefits from stock based compensation, amount                   0
Deemed dividend on exchange of merger warrants to Series I warrants and common stock, shares             48,786      
Deemed dividend on exchange of merger warrants to Series I warrants and common stock, amount             $ 5 316,856   (316,861)
Deemed dividend on modification of H-4 Warrants and issuance of Series J Warrants               1,019,040 (1,019,040)  
Deemed dividend on modification of H-4 Warrants               63,760 (63,760)  
Conversion of preferred stock into common stock, shares         (224)   14,653      
Conversion of preferred stock into common stock, amount             $ 1 (1)    
Net loss                 (18,749,163) (18,749,163)
Ending balance, shares at Dec. 31, 2018 0 0 8 2,189 26,619   1,633,394      
Ending balance, amount at Dec. 31, 2018 $ 0 $ 0 $ 0 $ 0 $ 3   $ 163 32,791,951 (29,753,721) 3,038,396
Issuance of Series A Preferred stock for services, shares             116,666      
Issuance of Series A Preferred stock for services, amount             $ 222,200      
Issuance of common stock for cash, shares             478,469      
Issuance of common stock for cash, amount             $ 48 1,984,953   1,985,001
Exercise of warrants, shares             277,778      
Exercise of warrants, amount             $ 28 16,639   16,667
Issuance of common shares in connection with exercise of H-4 warrants, shares         (21,591)   1,412,420      
Issuance of common shares in connection with exercise of H-4 warrants, amount         $ (2)   $ 141 (139)   0
Stock based compensation for options issued to employees               86,811   86,811
Stock based compensation for restricted stock units issued to employees               289,842   289,842
Stock based compensation for common stock issued to service providers, shares             116,666      
Stock based compensation for common stock issued to service providers, amount             $ 12 222,188   222,200
Stock based compensation for restricted stock issued to the board of directors, amount               25,000   25,000
Issuance of common stock upon vesting of restricted stock units, shares             276,290      
Issuance of common stock upon vesting of restricted stock units, amount             $ 27 (27)   0
Common stock reserved and retired for excess tax benefits from stock based compensation, shares             (133,135)      
Common stock reserved and retired for excess tax benefits from stock based compensation, amount             $ (13) (193,176)   (193,189)
Issuance of Series H-5 preferred stock and warrants in private placement net of cost, shares           34,722        
Issuance of Series H-5 preferred stock and warrants in private placement net of cost, amount           $ 3   2,299,997   2,300,000
Deemed dividend on modification of H-4 Warrants               57,875 (57,875)  
Net loss                 (4,902,383) (4,902,383)
Ending balance, shares at Dec. 31, 2019 0 0 8 2,189 5,028 34,722 4,061,882      
Ending balance, amount at Dec. 31, 2019 $ 0 $ 0 $ 0 $ 0 $ 1 $ 3 $ 406 $ 37,581,914 $ (34,713,979) $ 2,868,345